FDA Inspection 1221161 — Telomerix Stem Cell Biobank LLC
The FDA completed an inspection of Telomerix Stem Cell Biobank LLC on September 13, 2023 in Chesapeake, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 13, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Chesapeake, VA (United States)